Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target

Published:2020-01 Issue: Volume:78 Page:106087
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Hashemi Vida,Maleki Leili Aghebati,Esmaily Maryam,Masjedi Ali,Ghalamfarsa Ghasem,Namdar Afshin,Yousefi Mehdi,Yousefi Bahman,Jadidi-Niaragh Farhad

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference183 articles.

1. Novel therapies in breast cancer: what is new from ASCO 2008;Chu;J. Hematol. Oncol.,2008

2. Current status of treatment for early-stage invasive breast cancer;Kásler;Orv. Hetil.,2009

3. Cancer IAfRo. World Cancer Report: World Health Organization. IARC Press, 2003.

4. Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: a meta-analysis;Hu;Oncotarget,2017

5. The immunobiology of cancer immunosurveillance and immunoediting;Dunn;Immunity,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs;International Immunopharmacology;2024-11

2. Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects;Cells;2024-09-11

3. Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence;International Journal of Molecular Sciences;2024-06-13

4. Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity;Advanced Biology;2024-05-10

5. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations;Journal of Drug Delivery Science and Technology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3